NCT00920712

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 15, 2009

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2009

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

April 19, 2016

Status Verified

August 1, 2009

Enrollment Period

2.8 years

First QC Date

June 11, 2009

Last Update Submit

April 18, 2016

Conditions

Gastritis

Keywords

chronic atrophic gastritisTraditional Chinese Medicine

Outcome Measures

Primary Outcomes (1)

  • Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change

    12 weeks

Secondary Outcomes (1)

  • Indicates of liver and renal function

    12 weeks

Study Arms (2)

Weiqi decoction

EXPERIMENTAL
Drug: Weiqi decotion

low dose of Weiqi decoction

PLACEBO COMPARATOR
Drug: Weiqi decotion

Interventions

Weiqi decotionDRUG

Decoction ,two times a day

Weiqi decoctionlow dose of Weiqi decoction

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Chronic Atrophic Gastritis
  • Male of female patients between 18-65 years old
  • Written informed consent

You may not qualify if:

  • Combine with malignant pathology on epithelial dysplasia of gastric mucosa
  • Combine with duodenal ulcer or gastric ulcer
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Longhua hospital

Shanghai, Shanghai Municipality, 200032, China

Location

MeSH Terms

Conditions

GastritisGastritis, Atrophic

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesStomach Diseases

Study Officials

  • Xie Jianqun, Phd

    Shanghai University of Chinese Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2009

First Posted

June 15, 2009

Study Start

August 1, 2009

Primary Completion

June 1, 2012

Study Completion

July 1, 2012

Last Updated

April 19, 2016

Record last verified: 2009-08

Locations

CN(1)